We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

A Bright Future for RNA Therapeutics

Advances in RNA therapeutics, accelerated by the COVID-19 pandemic, hold promise for personalized treatments against various diseases.

Article  
Published: November 22, 2024 
RJ Mackenzie
 speaking with 
Brian Brown, PhD , 
Samir Mitragotri, PhD
 & John Cooke, PhD
One in-focus strand of RNA with a background of blurred strands.
Credit: iStock

The COVID-19 pandemic changed our society, and the technology that powers it, in an instant. Suddenly, remote working, telehealth and online learning boomed. One rapid change was in RNA biology – developing mRNA vaccines against COVID-19 helped us beat the virus into retreat faster than many could have hoped.

 

Now, advances in RNA biology promise rapid, personalized and flexible treatments against multiple diseases. In this article, we will explore whether RNA therapeutics can realize their full potential. If they do, their impact against COVID-19 will be only an overture.

Sponsored by

Meet the Author
A greyscale headshot of RJ Mackenzie
RJ Mackenzie
Freelance Science Writer & Journalist
RJ is a freelance science writer based in Glasgow. He covers biological and biomedical science, with a focus on the complexities and curiosities of the brain and emerging AI technologies. RJ was a science writer at Technology Networks for six years. RJ has a Master’s degree in Clinical Neurosciences from the University of Cambridge.
Interviewing
White letters "BB" on a navy background.
Brian Brown, PhD
Director of the Icahn Genomics Institute
Dr. Brian Brown is a molecular biologist and immunologist. He is director of the Icahn Genomics Institute (IGI) at Mount Sinai.
White letters "SM" on a navy background.
Samir Mitragotri, PhD
Hiller Professor of Bioengineering
Dr. Samir Mitragotri is a bioengineer and Hiller Professor of Bioengineering and Hansjörg Wyss Professor of Biologically Inspired Engineering at Harvard University.
White letters "JC" on a navy background.
John Cooke, PhD
Joseph C. “Rusty” Walter and Carole Walter Looke Presidential Distinguished Chair in Cardiovascular Disease Research
Dr. John Cooke is director of the Center for Cardiovascular Regeneration and medical director of the Center for RNA Therapeutics at Houston Methodist.
View this Article for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter